Cite
HARVARD Citation
Erdmann, E. et al. (2016). Ten‐year observational follow‐up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes. Diabetes, obesity & metabolism. 18 (3), pp. 266-273. [Online].